This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene (CNC) Receives DMHC Approval for Magellan Acquisition
by Zacks Equity Research
Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.
Magellan (MGLN) Unit to Unveil Wellbeing Program for Members
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - partners with NeuroFlow to launch a wellbeing solution for empowering MGLN's members in independently managing their health issues.
Why Buying Molina Healthcare (MOH) is a Prudent Move Now?
by Zacks Equity Research
Molina Healthcare's (MOH) total revenues for 2021 are anticipated to be no less than $27.5 billion.
Magellan (MGLN) Unit Ties Up to Offer Solution for Older Adults
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - joins forces with DUOS to offer a digital solution for easing the independent living of older adults at homes.
New Strong Sell Stocks for December 20th
by Zacks Equity Research
AVYA, TALO, VIOT, SBUX, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on December 20, 2021
Acadia Healthcare (ACHC) Forms JV to Better Serve Minnesota
by Zacks Equity Research
Acadia Healthcare (ACHC) joins forces with Fairview Health Services for delivering improved behavioral health services throughout the Twin Cities region.
Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details
by Zacks Equity Research
Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.
New Strong Sell Stocks for November 17th
by Zacks Equity Research
COLD, BRKS, CURO, FSTR, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on November 17, 2021.
Acadia Healthcare (ACHC) Inks JV to Boost Chula Vista Presence
by Zacks Equity Research
Acadia Healthcare (ACHC) teams up with Scripps Health in a bid to deliver high-quality behavioral health services across Chula Vista and the neighboring communities.
New Strong Sell Stocks for November 9th
by Zacks Equity Research
MGLN, SAND, UFCS, WW, and ZBH have been added to the Zacks Rank #5 (Strong Sell) List on November 9, 2021.
Magellan (MGLN) Q3 Earnings Decline Y/Y on Elevated Costs
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results reflect impact of rising expenses, partly offset by top-line growth and net new business growth in the Healthcare segment.
New Strong Sell Stocks for October 7th
by Zacks Equity Research
BE, ACMR, GPOR, NFE, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on October 7, 2021
Magellan (MGLN) Unit Launches Solution to Improve Behavioral Care
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - together with NeuroFlow, introduces a collaborative care management solution in a bid to ease the behavioral health treatment process.
Magellan (MGLN) Unveils Program to Improve Members' Mental Health
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - launched eMbolden program for offering improved behavioral health outcomes for employees and specific clients.
4 Health Insurance Companies Poised for Growth in 2H21
by Srijita Guha
Strategic initiatives, rising enrolment and strength in Medicaid business are expected to aid health insurance companies like CNC, ANTM, MOH and UNH in 2H21.
Magellan (MGLN) Q2 Earnings Decline Y/Y on High Expenses
by Zacks Equity Research
Magellan Health's (MGLN) second-quarter results dampened by escalating expenses, partly offset by growth in revenues and Healthcare segment.
Why Fast-paced Mover Magellan Health (MGLN) Is a Great Choice for Value Investors
by Zacks Equity Research
Magellan Health (MGLN) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Encompass Health (EHC) Continues to Boost Presence in Florida
by Zacks Equity Research
Encompass Health (EHC) plans to construct an inpatient rehabilitation hospital in Florida in a bid to offer improved health outcomes across the state.
Teladoc (TDOC), Microsoft Team Up to Offer Better Virtual Care
by Zacks Equity Research
Teladoc Health (TDOC) collaborates with Microsoft in a bid to ease administrative workflows for clinicians and offer enhanced virtual care to patients.
Why Should You Add Anthem (ANTM) Stock to Your Portfolio?
by Zacks Equity Research
Aided by high revenues and strong Medicaid and Medicare businesses, Anthem (ANTM) holds enough potential to reap benefits for investors.
Humana (HUM) Joins Montefiore Health for Better Healthcare
by Zacks Equity Research
Humana (HUM) inks a deal with Montefiore Health System to better serve Humana Medicare Advantage members in Bronx, Westchester and Hudson Valley.
Here's Why You Should Add Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Molina Healthcare (MOH) appears a lucrative investment option at the moment backed by strategic initiatives and healthy revenue stream.
Encompass Health (EHC), Altru Forms JV to Serve North Dakota
by Zacks Equity Research
Encompass Health (EHC) inks JV with Altru for sharing responsibility of operating the latter's inpatient rehabilitation hospital and offer better health outcomes across North Dakota.
Fast-paced Momentum Stock Magellan Health (MGLN) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Magellan Health (MGLN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Centene (CNC) Offers Senior Notes Priced at $1.8 Billion
by Zacks Equity Research
Centene (CNC) exhibits prudence in issuing notes to procure funds for executing the transaction of its Magellan Health acquisition.